Filing Details
- Accession Number:
- 0001140361-17-010999
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-08 15:51:08
- Reporting Period:
- 2017-03-06
- Filing Date:
- 2017-03-08
- Accepted Time:
- 2017-03-08 15:51:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 943819 | Resmed Inc | RMD | Surgical & Medical Instruments & Apparatus (3841) | 980152841 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1186102 | C Peter Farrell | Resmed Inc. 9001 Spectrum Center Boulevard San Diego CA 92123 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Common Stock | Acquisiton | 2017-03-06 | 16,085 | $33.70 | 317,642 | No | 4 | M | Direct | |
| Resmed Common Stock | Acquisiton | 2017-03-06 | 3,915 | $27.58 | 321,557 | No | 4 | M | Direct | |
| Resmed Common Stock | Disposition | 2017-03-06 | 20,000 | $71.70 | 301,557 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Resmed Common Stock | Resmed Stock Option Plan | Disposition | 2017-03-06 | 16,085 | $0.00 | 16,085 | $33.70 |
| Resmed Common Stock | Resmed Stock Option Plan | Disposition | 2017-03-06 | 3,915 | $0.00 | 3,915 | $27.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-11-11 | 2017-11-11 | No | 4 | M | Direct |
| 242,460 | 2012-11-11 | 2018-11-16 | No | 4 | M | Direct |
Footnotes
- The transaction was conducted under a Rule 10b5-1 plan.
- This transaction was executed in multiple trades at prices ranging from 71.48 to 71.97. The price reported above represents the weighted average sales price.
- Represents date options first became exercisable. Options vested 1/4 per year.
Billionaire Hedge Funds
